Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Sea vegetables, such as kelp, wakame, and nori, have been studied for their potential role in supporting the prevention of blood clots due to their content of bioactive compounds, particularly sulfated polysaccharides like fucoidan. Several in vitro and animal studies have shown that these compounds can have anticoagulant (blood-thinning) effects, sometimes comparable to heparin, a commonly used clinical anticoagulant. Fucoidan and other related compounds appear to interfere with the coagulation cascade, potentially reducing the risk of thrombosis (blood clot formation).

However, while the biochemical mechanisms are increasingly understood and preclinical research is promising, there is very limited direct clinical evidence in humans to support the use of sea vegetables or their extracts as a reliable means to prevent blood clots. Most of the available studies are preclinical, and human trials are scarce. Traditional East Asian diets, which are rich in sea vegetables, are sometimes associated with lower rates of cardiovascular disease, but causality and specific effects on clot prevention are not well established.

In summary, the use of sea vegetables for blood clot prevention is supported by early scientific research but lacks robust clinical validation. Caution should be exercised, especially for individuals on anticoagulant medication, as interactions are possible. The overall evidence level is low to moderate (2 out of 5), primarily based on laboratory and animal research rather than large-scale human studies.

More about Sea vegetable (unspecified)
More about Blood Clots (prevention of)

Other ingredients used for Blood Clots (prevention of)

Other health conditions supported by Sea vegetable (unspecified)

Products containing Sea vegetable (unspecified)